RNA Sequencing Market size is valued at $ 11.6Bn by 2019, and is anticipated to grow at a CAGR of 4.1% during the forecast period 2020-2025. The RNA Sequencing Market growth rate is attributed to the reduced cost of genetic sequencing, advancements in sequencing technology like Ion Semiconductor Sequencing, De Novo Transcriptome Assembly, etc. and next generation sequencing for cancer treatment. The process also helps to analyze the constantly changing cellular transcriptome; identifies gene fusion, post transcriptional modifications, & splicing; and recognizes the exon/intron boundary of the eukaryotic genes. From improvement’s made to enhance sequencing technology to the rise in number of partnerships & collaborations and its acceptance amongst the mass is anticipated to propel the RNA Sequencing Market during the forecast period 2020-2025.
Sequencing Type – Segment Analysis
Sequencing Platforms and Consumables held the largest share in the market owing to its increase in the availability of cost-effective and innovative sequencing platforms. Also, there is an emerging need for new platforms for accurate RNA data interpretation and advancements made in bioinformatics study has resulted in the increase in the number of start-ups for developments of Sequencing Software. Furthermore, the acceptance of various RNA Sequencing Platforms over the conventional testing’s and increase in adoption of personalized medicine is anticipated to boost the market growth in the forecast period of 2020-2025.
Request for Sample of the Report @ https://www.industryarc.com/pdfdownload.php?id=502466
Report Price: $ 4500 (Single User License)
Application Type- Segment Analysis
Based on Application type, expression profiling segment held the major share of the market in terms of revenue and is set to grow with a CAGR of 3.8%. The reason may be attributed to the factors like increasing prevalence of metabolic disorders, multiple sclerosis, and other diseases. Expression profiling section of RNA Sequencing is believed to rise effectively as demands from regions are emerging with technological advancements as this analysis provides specific treatment options for the diagnosis of the various chronic disorders which is anticipated to further expand the market base over the projection period of 2020-2025.
By Geography – Segment Analysis
North America dominated the RNA Sequencing Market with a share of 36% in 2019. The application of RNA Sequencing has grown rapidly over the last few years owing to the increasing research on cancer & inherited rare diseases, rapid advancements in RNA-Seq products and consumables continues to expand its market. Surging levels of investment for research activities in cancer as well as in agriculture sector with the presence of key players in the region and government supporting through funds are to cater the RNA Sequencing Market in the forecast period of 2020-2025.
Drivers – RNA Sequencing Market
Rising demand for RNA Sequencing over the Conventional Technologies
The rise in demand RNA Sequencing Platforms over the conventional technologies is owing to the fact that RNA-seq has higher sensitivity for genes expressed either at low or very high level and higher dynamic range of expression levels over which transcripts can be detected (>8000-fold range). Apart from this the capabilities of high-throughput sequencing methods to provide insight into the transcriptome of a cell compared to previous conventional technologies and recent advances in the RNA-Seq workflow, from sample preparation to library construction to data analysis altogether plays as a RNA Sequencing key driver of the market during the forecast period.
Talk to one of our sales representative about the full report by providing your details in the link below:
Challenges – RNA Sequencing Market
High initial capital and limited approaches
The major challenge for the market is the high initial capital investment on infrastructure and the requirements for skilled professionals and problems associated with storage of sequencing data. The RNA-based mappings depend on cDNA synthesis which poses a challenge in short-lived transcripts such as primary microRNAs, the efficiency of which is dependent on RNA sequence and structure are amongst the technical drawbacks which are to hinder the market growth in the forecast period.
RNA Sequencing Industry Outlook
Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the RNA Sequencing Market. In 2019, RNA Sequencing Market share was fragmented by the top ten players present in the market. RNA Sequencing Market top 10 companies are Thermo Fischer Scientific, Agilent Technologies Inc., Illumina, Tecan Genomics Inc., F. Hoffmann-La Roche Ltd, PerkinElmer Inc., GE Healthcare, Bio-Rad Laboratories Inc., Sigma Aldrich, Eurofins Scientific and others.
In March 12, 2020 Thermo Fisher Scientific Signs Agreement with Janssen Research & Development, LLC scientists to validate multiple biomarkers for use with Thermo Fisher’s Oncomine Dx Target Test, which is a next-generation sequencing (NGS) assay that contains 46 cancer-related biomarkers and a workflow that features a fast turnaround time and the lowest sample requirements on the market for detection of both DNA and RNA variants used to identify variant-positive patients for enrollment into clinical trials focused on non-small cell lung cancer (NSCLC).
In October 11, 2018 QIAGEN N.V. launched novel RNA-seq library preparation solutions for next-generation sequencing.
In June 2017, Agilent Technologies and Agendia declared an agreement to expand the relationship which include the development of Agendia’s RNA-Seq kit version into Agilent’s current product portfolio.
North America dominated the RNA Sequencing Market with a share of 36% in the year 2019.
The factors such as increasing number of RNA-sequence grants, acceptance amongst the mass, improved reimbursement coverage for such diagnostic tests, etc. are amongst the major factor projected to impel growth of RNA Sequencing Market.
Increase in adoption of personalized medicine, increased utility in patient stratification and therapeutic response research, and significant external funding for executing research and development are the key factors owing to the growth in the segment during forecast period 2020-2025.
Related Reports :
A. Next Generation Sequencing Market
B. RNA Analysis/Transcriptomics Market
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to firstname.lastname@example.org to discuss more about our consulting services.